Sponsor Collaborators Module
The Sponsor Collaborators Module contains information about the sponsors and collaborators involved in the clinical trial. This includes lead sponsor details, responsible party information, investigator information, and collaborator organizations that are supporting or conducting the study.
Sponsor Collaborators Module path is as follows:
Study -> Protocol Section -> Sponsor Collaborators Module -> Collaborators
Sponsor Collaborators Module
Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-25 @ 9:26 PM
NCT ID:
NCT04674956
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Study:
NCT04674956
Study Brief:
A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer
Protocol Section:
NCT04674956
Collaborators (If Any):